Chengdu
Sichuan Province
Anticancer Bioscience
is a China-based biotechnology company that develops and commercializes synthetic lethal-based therapies for the treatment of cancer... Read moreAnticancer Bioscience
is a China-based biotechnology company that develops and commercializes synthetic lethal-based therapies for the treatment of cancer... Read moreNews
May 18, 2022
FirstWord Pharma
Anticancer Bioscience: DelSiTech and Anticancer Bioscience Announce a Collaboration Agreement for the Development of Long-acting Therapies in Oncology
Oct 18, 2021
FinSMEs
Anticancer Bioscience: Anticancer Bioscience Raises Additional USD 10.6M; Closes Over $31M Seed Round
Oct 14, 2021
Pharmafile
Anticancer Bioscience: Anticancer Bioscience receives additional $10.6 investment into cancer therapy
Oct 14, 2021
BioSpace
Anticancer Bioscience: Anticancer Bioscience Welcomes New Investor into Seed Financing Round Bringing Total Raised to Over $31m to Advance Synthetic Lethality Approaches to Cancer Therapy
Oct 14, 2021
Pharmafile
Anticancer Bioscience: Anticancer Bioscience receives additional $10.6m investment into cancer therapy
Jul 14, 2021
FierceBiotechIT
Anticancer Bioscience: ACB hires Liu from Eureka Therapeutics to lead push into clinic
May 11, 2021
MarketScreener
Anticancer Bioscience: Anticancer Bioscience : Announces Preclinical Data of Lead Compounds Against Novel Myc Synthetic Lethal Target in Cancer
Mar 02, 2021
StreetInsider
Press Release: Anticancer Bioscience : Anticancer Biosciences is developing a new antimitotic cancer therapeutics using natural products
Feb 08, 2021
FinSMEs
Anticancer Bioscience: Anticancer Bioscience Raises Approx. USD10M in Financing
Jan 13, 2021
FinanzNachrichten
Anticancer Bioscience: Reportable, Inc.: Anticancer Bioscience Presenting at Biotech Showcase Digital 2021 Showcasing its Synthetic Lethal Precision Oncology Pipeline for the First Time